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ABSTRACT Mycobacterium kansasii is a nontuberculous mycobacterial (NTM) patho-
gen, frequently isolated from clinical samples and responsible for a large part of
NTM infections in the human population. Here, we report the draft genome se-
quences of 12 M. kansasii strains isolated from clinical and host-associated sources
from the Netherlands, Germany, and Poland.
Mycobacterium kansasii is one of the most significant nontuberculous mycobacte-rial (NTM) pathogens recovered from clinical specimens and is responsible for a
large part of NTM infections in the human population (1, 2). However, culturing of
M. kansasii from human tissues may not necessarily represent true infection but rather
a nonpathogenic colonization. Grouping of M. kansasii into seven genetically similar
subtypes (I to VII) adds more complexity to the clinical and epidemiological relevance
of M. kansasii isolations. Of the M. kansasii subtypes, type I has been isolated most
frequently from human sources and involved in the causation of NTM disease (3–5).
To better explore the genetic diversity of M. kansasii and recognize the effect of
genetic background on the bacterial phenotype, the first large-scale M. kansasii ge-
nome sequencing project has been launched (6). The project operates on a diverse pool
of M. kansasii strains, of both environmental and clinical origin, from different geo-
graphical locales. The key purpose of the research is to identify molecular markers,
specifically those associated with the pathogenic phenotype. This could lead to a new
method for a fast and reliable diagnosis of M. kansasii disease.
Here, we announce the draft genome sequences of 12 clinical and host-associated
M. kansasii strains, representing three subtypes—namely, I, II, and VI. The strains were
recovered from pulmonary clinic patients in the Netherlands, Germany, and Poland and
were sequenced, as summarized in Table 1.
Genomic DNA was extracted and purified using the protocol of van Embden et al.
(7). Genotyping was performed by means of PCR-restriction endonuclease analysis for
the hsp65 and tuf genes, as previously described (4, 8). Illumina paired-end libraries
were prepared with the Nextera XT kit, in accordance with the manufacturer’s instruc-
tions. Whole-genome shotgun sequencing was performed on the MiSeq platform
(Illumina) at a read length of 2  250 bp.
A total of 1,261,159, 1,274,864, 1,348,130, 1,609,452, 1,549,556, 1,498,034, 1,616,934,
1,386,880, 1,714,844, 1,390,906, 1,207,915, and 1,151,718 reads were obtained for strains
NLA001000927, NLA001001166, NLA001001128, NLA001000449, NLA001000521, ATCC
25221, B11073207, B11063838, 7728, 6200, 7744, and 2193, respectively. The draft ge-
nomes of genotype I strains were de novo assembled with SPAdes software version
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3.7.1 (9), with manual editing using FA_TOOL (10). The resulting assemblies were
scaffolded with MeDuSa software (11). De novo assemblies of genotype II and VI strains
were prepared using SPAdes version 3.7.1, Abyss version 2.0.2 (12), and Ray version
2.3.1 (13) simultaneously. To improve assembly contiguity, the obtained sets of contigs
were integrated using CISA version 1.3 (14). The scaffolding process was performed by
CONTIGuator (15), while gap closing was done with GapBlaster version 1.1.1 (16).
Annotation was carried out automatically using the NCBI Prokaryotic Genome Anno-
tation Pipeline (http://www.ncbi.nlm.nih.gov/genome/annotation_prok). The total
lengths of the contigs for each genome, along with some basic clinical data regarding
the strains, are presented in Table 1.
Accession number(s). The accession numbers of the draft genome sequences of
the M. kansasii strains reported here are provided in Table 1.
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